What is Neocera?
Neocera operates at the intersection of advanced materials science and industrial manufacturing, serving as a critical provider of thin-film products and pulsed laser deposition (PLD) systems. By delivering high-precision diagnostic tools and deposition components, the company enables multinational corporations and academic institutions to push the boundaries of material research. Their proprietary technology, including pulsed electron deposition (PED) systems, positions them as a foundational supplier for semiconductor failure analysis and R&D environments. As a pioneer in the field, Neocera bridges the gap between laboratory-scale innovation and large-scale industrial application, ensuring that researchers have the necessary infrastructure to develop next-generation electronic components.
How much funding has Neocera raised?
Neocera has raised a total of $317K across 1 funding round:
Debt
$317K
Debt (2021): $317K with participation from PPP
Key Investors in Neocera
PPP
Public-Private Partnership
What's next for Neocera?
Following this late-stage financing, Neocera is well-positioned to scale its manufacturing capabilities and expand its footprint within the global semiconductor supply chain. The infusion of capital will likely be directed toward enhancing the integration of their diagnostic tools with existing deposition platforms, thereby increasing the value proposition for their enterprise clients. As the demand for sophisticated failure analysis grows in tandem with the complexity of modern chip architecture, Neocera's strategic focus will remain on maintaining its leadership in PLD technology while exploring new avenues for in situ diagnostic integration. This growth phase suggests a transition toward broader market penetration and the potential for further technological diversification in the materials development space.
See full Neocera company page
